As we close the book on 2022, the Helix team was busier than ever in pursuit of our mission to empower every person to improve their life through DNA. Some key highlights: New health system partners: We were excited to share the news of three new health system partnerships this year. In March, we announced  … Read more

As the Chief Physician Executive of WellSpan Health, Dr. Anthony Aquilina sees meaningful benefits of getting genetic insights into the hands of the providers. WellSpan Health and Helix recently announced a new partnership to create a comprehensive population-scale genetic screening program for Pennsylvanians. We sat down to chat with Dr. Aquilina about the value he  … Read more

Genomics is a powerful tool for improving health outcomes in both individuals and the population as a whole. Population-level genomic studies are essential to lay the groundwork for effective genomic screening of individuals, but genomic data from many underserved communities is lacking. Developing effective outreach to these communities can be difficult as standard approaches for  … Read more

Genomic testing has been used for years on a case-by-case basis in clinical care, but is now increasingly seen as an important contributor to advancing population health. In September, Feby Abraham, PhD, Chief Strategy Officer of Houston-based Memorial Hermann Health System, and James Lu, MD, PhD, co-founder and CEO of Helix, came together to discuss  … Read more

Many health system leaders feel that clinician access to a patient’s heritable risks for actionable health conditions is an important step towards being able to eventually provide comprehensive precision medicine.  And yet most organizations that utilize genomics today are still only doing so with a fraction of their population and through very specific service lines  … Read more

As health systems work towards providing more targeted, personalized care to patients, it is crucial that identified solutions not only enhance the patient experience but also increase provider satisfaction, reduce overall healthcare costs and improve population health. The promise of genomic-led medicine is exciting but it is critical that we understand where and how it  … Read more

With the rising popularity of wearable devices, more patients than ever are reporting self-diagnoses of atrial fibrillation to their doctors. Because early treatment of heart conditions can be critical in slowing their progression, identifying individuals in the early stages of heart failure may significantly improve their chances of delaying or preventing negative – or sometimes even  … Read more

Genomic testing has been used for years as a point solution in isolated clinical care but is now increasingly viewed as a potential solution to health screening on a much larger scale. In March, James Lu, MD, PhD, co-founder and CEO of Helix, and Leslie Dockan, RN, Vice President of Primary Care and Operations at  … Read more

In September this year, the Medical University of South Carolina (MUSC) officially announced their entry into the fast-expanding space of population genomics with the launch of the In Our DNA SC program. In partnership with Helix, MUSC aims to recruit 100,000 participants from diverse communities across the state over the next four years. Similarly to other population  … Read more